| Medical and Health Sciences | 2021-2025 | 732 | US 252 | 99.83 |
| Clinical Neurology | Lifetime | 44 | US 18 | 99.85 |
| Pathology and Forensic Medicine | Lifetime | 46 | US 25 | 99.82 |
| Rheumatology | Lifetime | 886 | US 407 | 94.90 |
| Clinical Neurology | 2021-2025 | 13 | US 5 | 99.63 |
| Pathology and Forensic Medicine | 2021-2025 | 15 | US 6 | 99.64 |
| Immunology | 2021-2025 | 861 | US 316 | 69.56 |
| Peripheral Neuropathies and Disorders | Lifetime | 6 | US 1 | 99.90 |
| Multiple Sclerosis Research Studies | Lifetime | 16 | US 7 | 99.82 |
| Autoimmune Neurological Disorders and Treatments | Lifetime | 5 | US 2 | 99.80 |
| Systemic Lupus Erythematosus Research | Lifetime | 119 | US 50 | 99.48 |
| Myasthenia Gravis and Thymoma | Lifetime | 44 | US 14 | 99.07 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 105 | US 50 | 98.55 |
| Polyomavirus and related diseases | Lifetime | 308 | US 153 | 97.37 |
| Genetic Neurodegenerative Diseases | Lifetime | 548 | US 209 | 97.13 |
| Long-Term Effects of COVID-19 | Lifetime | 932 | US 207 | 94.38 |
| Sphingolipid Metabolism and Signaling | Lifetime | 895 | US 329 | 89.52 |
| Protein Tyrosine Phosphatases | Lifetime | 907 | US 332 | 86.03 |
| Pathogenesis and Treatment of Hiccups | Lifetime | 343 | US 130 | 73.04 |
| Whipple's Disease and Interleukins | Lifetime | 788 | US 227 | 55.29 |
| Peripheral Neuropathies and Disorders | 2021-2025 | 2 | US 2 | 99.86 |
| Multiple Sclerosis Research Studies | 2021-2025 | 17 | US 6 | 99.59 |
| Autoimmune Neurological Disorders and Treatments | 2021-2025 | 7 | US 5 | 99.35 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 280 | US 73 | 96.05 |
| CNS Lymphoma Diagnosis and Treatment | 2021-2025 | 119 | US 53 | 92.60 |
| Myasthenia Gravis and Thymoma | 2021-2025 | 170 | US 35 | 89.89 |
| Genetics and Neurodevelopmental Disorders | 2021-2025 | 973 | US 317 | 82.57 |
| Polyomavirus and related diseases | 2021-2025 | 409 | US 136 | 83.01 |
| Cellular transport and secretion | 2021-2025 | 653 | US 208 | 75.67 |
| RNA regulation and disease | 2021-2025 | 867 | US 229 | 70.26 |
| Protein Tyrosine Phosphatases | 2021-2025 | 269 | US 76 | 67.23 |
| Glycogen Storage Diseases and Myoclonus | 2021-2025 | 823 | US 168 | 49.35 |
| Cerebrovascular and genetic disorders | 2021-2025 | 842 | US 147 | 29.86 |
| Parkinson's Disease and Spinal Disorders | 2021-2025 | 797 | US 153 | 22.81 |
| Caveolin-1 and cellular processes | 2021-2025 | 537 | US 156 | 17.23 |
